In a national study, a group of researchers from Qatar University (QU) has investigated the efficiency of Pfizer and Moderna vaccines against the Delta Sars-CoV-2 variant.
Many kinds of research were conducted in Qatar by the National Committee for Covid-19 to find out the effect of the mRNA-vaccine among community members.
QU College of Health Sciences (CHS) dean Dr Hanan Abdel Rahim, Department of Biomedical Sciences associate professor Dr Gheyath K Nasrallah, and Biomedical Sciences Research Center's Dr Hadi Mohamad Yassine, Dr Hebah AlKhatib and Dr Fatiha Benslimane have published a related article in the journal Nature Medicine.
The Sars-CoV-2 (which causes Covid-19) mutant is an emerging strain of coronavirus that was first identified two years ago in Wuhan City, Hebei Province, China. Research and studies around the world pay great attention to knowing how Covid-19 disease spreads to find the proper treatment and vaccination for it.
The first dose of the Covid-19 vaccine was given to nearly four billion people around the world. Since the beginning of the pandemic, more than 23,900 people have contracted Covid-19 in Qatar, of whom 611 have died. Qatar is considered one of the countries with the highest vaccination rates in the world, as 84.3% of its population received two doses of vaccination.
More about the paper can be read by following this link: